Synthesis of new cyclopropanated tryptamine analogues

Synlett

Volumn , Issue 10, 2008, Pages 1479-1482

  Szalata, Claude ^a   Sapi, Janos ^a   Szymoniak, Jan ^a   Bertu, Philippes ^a,b   Gérard, Stéphane ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b UNIVERSITÉ DU MAINE   (France)

Author keywords

Cyclopropanes; Indoles; Titanium; Transition metals; Tryptamines

Indexed keywords

ACETONITRILE DERIVATIVE; AMINE; CYCLOPROPANE DERIVATIVE; INDOLE DERIVATIVE; TRYPTAMINE DERIVATIVE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CYCLOPROPANATION; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTUM YIELD; REACTION ANALYSIS; SYNTHESIS;

EID: 46449100062     PISSN: 09365214     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1078426     Document Type: Article

References (40)

1. (a) Vilsmaier, E. In The Chemistry of the Cyclopropyl Group; Rappoport, Z., Ed.; Wiley: New York, 1987, 1341.
2. (b) Houben-Weyl, Vol. E17a-c; de Meijere, A., Ed.; Thieme: Stuttgart, 1997.
3. (a) Suckling, C. J. Angew. Chem., Int. Ed. Engl. 1988, 27, 537.
4. (b) Salaiin, J. Top. Curr. Chem. 2000, 207, 1.
5. (a) Wise, R.; Andrews, J. M.; Edwards, L. J. Antimicrob. Agents Chemother. 1983, 23, 559.
6. (b) Todo, Y.; Nitta, J.; Miyajima, M.; Fukuoka, Y.; Yamashiro, Y.; Nishida, N.; Saikawa, I.; Narita, H. Chem. Pharm. Bull. 1994, 42, 2063.
7. (c) Brighty, K. E.; Castaldi, M. J. Synlett 1996, 1097.
8. (d) Högberg, M.; Sahlberg, C.; Engelhardt, P.; Noréen, R.; Kangasmetsä, J.; Johansson, N. G.; Öberg, B.; Vrang, L.; Zhang, H.; Sahlberg, B.-L.; Unge, T.; Lövgren, S.; Fridborg, K.; Bäckbro, K. J. Med. Chem. 1999, 42, 4150.
9. (e) Daluge, S. M.; Martin, M. T.; Sickles, B. R.; Livingston, D. A. Nucleosides Nucleotides 2000, 19, 297.
10. (f) Tichenor, M. S.; MacMillan, K. S.; Stover, J. S.; Wolkenberg, S. E.; Pavani, M. G.; Zanella, L.; Zaid, A. N.; Spalluto, G.; Rayl, T. J.; Hwang, I.; Baraldi, P. G.; Boger, D. L. J. Am. Chem. Soc. 2007, 129, 14092; and references therein.
11. (a) Fujita, T. J. Med. Chem. 1973, 16, 923.
12. (b) N-Cyclopropyltryptamine was also described as a potent monoamine oxidase inhibitor. See: Winn, M.; Horrom, B. W.; Rasmussen, R. R.; Chappell, E. B.; Plotnikoff, N. P. J. Med. Chem. 1975, 18, 437.
13. Shimamoto, K.; Ishida, M.; Shinozaki, H.; Ohfune, Y. J. Org. Chem. 1991, 56, 4167.
14. Vangveragong, S.; Kanthasamy, A.; Lucaites, V. L.; Nelson, D. L.; Nichols, D. E. J. Med. Chem. 1998, 41, 4995.
15. Tsotinis, A.; Vlachou, M.; Papahatjis, D. P.; Calogeropoulou, T.; Nikas, S. P.; Garratt, P. J.; Piccio, V.; Vonhoff, S.; Davidson, K.; Teh, M.-T.; Sugden, D. J. Med. Chem. 2006, 49, 3509.
16. Raoul, M.; Patigny, D.; Fabis, F.; Dauphin, F.; Rault, S.; Sapi, J.; Laronze, J.-Y. J. Enzym. Inhib. Med. Chem. 2006, 251.
17. (a) Glennon, R. A. J. Med. Chem. 2003, 46, 2795.
18. (b) Holenz, J.; Mercè, R.; Diaz, J. L.; Guitart, X.; Codony, X.; Dordal, A.; Romero, G.; Torrens, A.; Mas, J.; Andaluz, B.; Hernandez, S.; Monroy, X.; Sanchez, E.; Hernandez, E.; Pérez, R.; Cubi, R.; Sanfeliu, O.; Bushchmann, H. J. Med. Chem. 2005, 48, 1781.
19. Sapi, J.; Grébille, Y.; Laronze, J.-Y.; Lévy, J. Synthesis 1992, 383.
20. (a) Bertus, P.; Szymoniak, J. Chem. Commun. 2001, 1792.
21. (b) For a review, see: Bertus, P.; Szymoniak, J. Synlett 2007, 1346.
22. An alternative approach involving the titanium-mediated cyclopropanation of N,N-dialkylamides should be envisioned, but requires the preparation of the amides. For the reaction, see: (a) Chaplinski, V.; de Meijere, A. Angew. Chem., Int. Ed. Engl. 1996, 35, 413.
23. (b) de Meijere, A.; Kozhushkov, S. I.; Savchenko, A. I. J. Organomet. Chem. 2004, 559, 2033.
24. For related applications, see: (c) Cao, B.; Xiao, D.; Joullié, M. M. Org. Lett. 1999, 1, 1799.
25. (d) Ouhamou, N.; Six, Y. Org. Biomol. Chem. 2003, 1, 3007.
26. (e) Gensini, M.; de Meijere, A. Chem. Eur. J. 2004, 10, 785.
27. (f) Larquetoux, L.; Kowalska, J. A.; Six, Y. Eur. J. Org. Chem. 2004, 3517.
28. (g) Larquetoux, L.; Ouhamou, N.; Chiaroni, A.; Six, Y. Eur. J. Org. Chem. 2005, 4654.
29. (h) Faler, C. A.; Joullié, M. M. Org. Lett. 2007, 9, 1987.
30. (a) Laroche, C.; Behr, J. B.; Szymoniak, J.; Bertus, P.; Plantier-Royon, R. Eur. J. Org. Chem. 2005, 5084.
31. (b) Laroche, C.; Plantier-Royon, R.; Szymoniak, J.; Bertus, P.; Behr, J.-B. Synlett 2006, 223.
32. (c) Pearson, M.; Plantier-Royon, R.; Szymoniak, J.; Bertus, P.; Behr, J. B. Synthesis 2007, 3589.
33. The ketone by-product might also be obtained by the hydrolysis of metallacycle B (Scheme 2). This assumption was ruled out by deuterolysis of the reaction media (no trace of deuterium was observed on the methyl moiety).
34. Bertus, P.; Szymoniak, J. Org. Lett. 2007, 9, 659.
35. Chaplinski, V.; Winsel, H.; Kordes, M.; de Meijere, A. Synlett 1997, 111.
36. 4) and evaporation of the solvents, the crude material was purified by flash chromatography (EtOAc).
37. 2S 327.1167; found: 327.1169.
38. The cyclopropanation of unprotected 8 gave only a low yield of the primary cyclopropylamine.
39. Street, L. J.; Baker, R.; Castro, J. L.; Chambers, M. S.; Guiblin, A. R.; Hobbs, S. C.; Matassa, V. G.; Reeve, A. J.; Beer, M. S.; Middlemiss, D. N.; Noble, A. J.; Stanton, J. A.; Scholey, K.; Hargreaves, R. J. J. Med. Chem. 1993, 36, 1529.
40. 2: 255.1861; found: 255.1855.